Patient Experience

A 28-year-old Bedouin goat herder from...
Aug 16, 2025

A 28-year-old Bedouin goat herder from the Negev presented with an aggressive osteosarcoma in his femur. Dr. Bar collaborated with tribal elders to create a culturally-sensitive treatment plan combining traditional herbal remedies with targeted radiation therapy, resulting in complete remission after 9 months.

A 72-year-old Holocaust survivor with metastatic...
Jul 26, 2025

A 72-year-old Holocaust survivor with metastatic melanoma had previously refused all treatment due to trauma from medical experiments. Dr. Bar spent weeks building trust through shared conversations in Yiddish, eventually developing a personalized immunotherapy regimen that achieved partial response with minimal side effects.

A 45-year-old Ethiopian immigrant single mother...
Aug 26, 2025

A 45-year-old Ethiopian immigrant single mother of four presented with advanced cervical cancer. Dr. Bar arranged housing near the hospital for her children during treatment and pioneered a combination of chemotherapy with experimental viral therapy, leading to tumor shrinkage and extended survival.

A 19-year-old ultra-Orthodox yeshiva student diagnosed...
May 04, 2025

A 19-year-old ultra-Orthodox yeshiva student diagnosed with testicular cancer faced religious conflicts regarding fertility preservation. Dr. Bar consulted with rabbinical authorities to develop a halachically-approved sperm banking solution before orchectomy, followed by successful treatment and full recovery.

A 33-year-old Palestinian journalist from Gaza...
May 31, 2025

A 33-year-old Palestinian journalist from Gaza with rare nasopharyngeal carcinoma received cross-border coordination for treatment. Dr. Bar worked with international mediators to ensure continuous care despite border closures, achieving complete remission after proton therapy.

An 81-year-old former NASA engineer with...
Aug 09, 2025

An 81-year-old former NASA engineer with glioblastoma multiforme collaborated with Dr. Bar on designing his own treatment protocol. They developed a novel combination of tumor-treating fields with customized chemotherapy, extending survival beyond statistical predictions by 18 months.

A 7-year-old Syrian refugee with acute...
Aug 01, 2025

A 7-year-old Syrian refugee with acute lymphoblastic leukemia had complex nutritional deficiencies from wartime deprivation. Dr. Bar created a comprehensive nutritional rehabilitation program alongside chemotherapy, resulting in successful remission and catch-up growth.

A 58-year-old diamond polisher from Antwerp...
Jul 07, 2025

A 58-year-old diamond polisher from Antwerp visiting Israel presented with mesothelioma from occupational asbestos exposure. Dr. Bar implemented hyperthermic intraperitoneal chemotherapy with complete cytoreduction, allowing the patient to return to work within a year.

A 29-year-old professional basketball player from...
Jun 22, 2025

A 29-year-old professional basketball player from Tel Aviv diagnosed with Hodgkin's lymphoma required preservation of athletic performance. Dr. Bar designed a precision radiation therapy protocol sparing cardiac and pulmonary function, enabling return to professional sports after treatment.

A 67-year-old retired fisherman from Jaffa...
Jun 07, 2025

A 67-year-old retired fisherman from Jaffa with hepatocellular carcinoma from chronic hepatitis C refused conventional treatment. Dr. Bar developed an alternative approach using radioembolization with yttrium-90 microspheres, achieving local control with preserved liver function.

A 41-year-old LGBTQ+ activist with metastatic...
May 18, 2025

A 41-year-old LGBTQ+ activist with metastatic breast cancer requested gender-affirming care alongside oncology treatment. Dr. Bar coordinated with endocrinology and plastic surgery to provide comprehensive care that respected gender identity while effectively treating cancer.

A 52-year-old Bedouin woman with advanced...
Jun 26, 2025

A 52-year-old Bedouin woman with advanced ovarian cancer had never previously visited a hospital. Dr. Bar arranged for female-only medical teams and incorporated family members into decision-making, leading to successful debulking surgery and chemotherapy completion.

A 35-year-old tech entrepreneur with pancreatic...
Jun 20, 2025

A 35-year-old tech entrepreneur with pancreatic neuroendocrine tumor sought experimental treatments. Dr. Bar enrolled the patient in a first-in-human peptide receptor radionuclide therapy trial, resulting in significant tumor regression and ongoing disease control.

Know More

Icon
Location

VO-284, Eldeco Centre 110017